IL91308A - תכשירי רוקחות המכילים נפתוקינון לטיפול בדלקות פנוימוציסטיס קריני ו/או מניעתן - Google Patents

תכשירי רוקחות המכילים נפתוקינון לטיפול בדלקות פנוימוציסטיס קריני ו/או מניעתן

Info

Publication number
IL91308A
IL91308A IL9130889A IL9130889A IL91308A IL 91308 A IL91308 A IL 91308A IL 9130889 A IL9130889 A IL 9130889A IL 9130889 A IL9130889 A IL 9130889A IL 91308 A IL91308 A IL 91308A
Authority
IL
Israel
Prior art keywords
group
naphthoquinone
compound
hydroxy
alkyl
Prior art date
Application number
IL9130889A
Other languages
English (en)
Other versions
IL91308A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819480A external-priority patent/GB8819480D0/en
Priority claimed from GB888819478A external-priority patent/GB8819478D0/en
Priority claimed from GB888819479A external-priority patent/GB8819479D0/en
Priority claimed from GB888819477A external-priority patent/GB8819477D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL91308A0 publication Critical patent/IL91308A0/xx
Priority to IL107407A priority Critical patent/IL107407A0/xx
Publication of IL91308A publication Critical patent/IL91308A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/12Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/30Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/24Quinones containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/26Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96Esters of carbonic or haloformic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/26All rings being cycloaliphatic the ring system containing ten carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
IL9130889A 1988-08-16 1989-08-15 תכשירי רוקחות המכילים נפתוקינון לטיפול בדלקות פנוימוציסטיס קריני ו/או מניעתן IL91308A (he)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL107407A IL107407A0 (en) 1988-08-16 1993-10-26 Naphthoquinone derivatives, their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888819480A GB8819480D0 (en) 1988-08-16 1988-08-16 Medicaments
GB888819478A GB8819478D0 (en) 1988-08-16 1988-08-16 Medicaments
GB888819479A GB8819479D0 (en) 1988-08-16 1988-08-16 Medicaments
GB888819477A GB8819477D0 (en) 1988-08-16 1988-08-16 Medicaments

Publications (2)

Publication Number Publication Date
IL91308A0 IL91308A0 (en) 1990-03-19
IL91308A true IL91308A (he) 1994-07-31

Family

ID=27450160

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9130889A IL91308A (he) 1988-08-16 1989-08-15 תכשירי רוקחות המכילים נפתוקינון לטיפול בדלקות פנוימוציסטיס קריני ו/או מניעתן

Country Status (20)

Country Link
EP (2) EP0362996B1 (he)
JP (1) JP2804302B2 (he)
AT (1) ATE178311T1 (he)
AU (1) AU633836B2 (he)
CA (1) CA1329621C (he)
CY (1) CY1863A (he)
DE (2) DE68914930T2 (he)
DK (1) DK175787B1 (he)
ES (2) ES2130199T3 (he)
FI (1) FI893835A (he)
HK (1) HK103395A (he)
HU (1) HU208624B (he)
IE (1) IE65715B1 (he)
IL (1) IL91308A (he)
LV (1) LV11273B (he)
MX (1) MX9202995A (he)
NZ (1) NZ230313A (he)
PT (2) PT91456B (he)
SA (1) SA95160138B1 (he)
SG (1) SG23618G (he)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
EP0567162A1 (en) * 1989-09-22 1993-10-27 The Wellcome Foundation Limited Medicaments for the treatment of toxoplasmosis
GB9103075D0 (en) * 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
GB9121316D0 (en) * 1991-10-09 1991-11-20 Wellcome Found Heterocyclic compounds
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9207517D0 (en) * 1992-04-06 1992-05-20 Wellcome Found Heterocyclic compounds
GB9216859D0 (en) * 1992-08-07 1992-09-23 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
AU3705695A (en) * 1994-10-26 1996-05-23 Wellcome Foundation Limited, The Pharmaceutical composition comprising atovaquone
GB9613309D0 (en) * 1996-06-25 1996-08-28 Univ Sheffield Quinone bacterial inhibitors
BRPI0513951A (pt) * 2004-07-30 2008-05-20 Japan Health Science Found agente antiprotozoário
WO2009007991A2 (en) 2007-04-19 2009-01-15 Ipca Laboratories Limited A new process for preparation of atovaquone and novel intermediates thereof
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
US9169232B2 (en) * 2011-09-16 2015-10-27 Alkem Laboratories Limited 3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug
KR20190020774A (ko) * 2016-06-20 2019-03-04 더 스크립스 리서치 인스티튜트 항말라리아 조성물 및 이의 용도
WO2022144920A1 (en) * 2020-12-30 2022-07-07 Ipca Laboratories Limited Atovaquone prodrugs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553424A (en) * 1976-02-10 1979-09-26 Wellcome Found Method of treating protozal diseases
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8500292D0 (en) * 1985-01-07 1985-02-13 Wellcome Found Treatment of babesiosis
DE3801743A1 (de) * 1987-07-03 1989-01-19 Bayer Ag Schaedlingsbekaempfungsmittel auf basis von substituierten 1,4-naphthochinonen und neue substituierte 1,4-naphthochinone

Also Published As

Publication number Publication date
DK175787B1 (da) 2005-02-21
AU3994889A (en) 1990-02-22
LV11273A (lv) 1996-06-20
HU208624B (en) 1993-12-28
LV11273B (en) 1996-10-20
PT91456B (pt) 1996-06-28
HUT57041A (en) 1991-11-28
CA1329621C (en) 1994-05-17
DE68914930D1 (de) 1994-06-01
IE65715B1 (en) 1995-11-15
PT101734B (pt) 1997-08-29
DE68914930T2 (de) 1994-08-18
CY1863A (en) 1996-04-05
DE68928964D1 (de) 1999-05-06
PT101734A (pt) 1996-01-31
FI893835A (fi) 1990-02-17
DK399989D0 (da) 1989-08-15
ES2052012T3 (es) 1994-07-01
PT91456A (pt) 1990-03-08
EP0362996B1 (en) 1994-04-27
ES2130199T3 (es) 1999-07-01
MX9202995A (es) 1992-07-01
IL91308A0 (en) 1990-03-19
EP0362996A3 (en) 1992-04-15
EP0580185A1 (en) 1994-01-26
DK399989A (da) 1990-02-17
NZ230313A (en) 1992-07-28
EP0580185B1 (en) 1999-03-31
IE892616L (en) 1990-02-16
EP0362996A2 (en) 1990-04-11
JPH0291037A (ja) 1990-03-30
SG23618G (en) 1995-09-18
SA95160138B1 (ar) 2006-03-15
AU633836B2 (en) 1993-02-11
DE68928964T2 (de) 1999-07-29
FI893835A0 (fi) 1989-08-15
HU911004D0 (en) 1991-10-28
JP2804302B2 (ja) 1998-09-24
ATE178311T1 (de) 1999-04-15
HK103395A (en) 1995-07-07

Similar Documents

Publication Publication Date Title
AP111A (en) Medicaments.
US5310762A (en) Medicaments
EP0362996B1 (en) Naphthoquinones for the treatment and prophylaxis of pneumocystis carinii infections
US20040138147A1 (en) Compounds and methods for treating transplant rejection
JPH0533212B2 (he)
DE69811905T2 (de) Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
US5225184A (en) Medicaments
EP0572615B1 (en) Medicament for the Treatment of Protozoal Infections caused by Babesia
IL107407A (he) תולדות 2-ת 4-)כלורופיניל( ציקלוהקסיל[-נאפתוקווינון, הכנתן ותכשירי רוקחות המכילים אותן
CA1336266C (en) Medicaments
AU776853B2 (en) Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of African and American Trypanosomiasis
KR0160758B1 (ko) 나프토퀴논
AU676687B2 (en) Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1, 4-naphthoquinone for the treatment of cancer
EP0496729B1 (en) Medicament for the treatment of cryptosporidiosis
DK175868B1 (da) 2- (4-chlorphenyl) cyclohexylnaphthoquinonderivater, fremgangsmåde til fremstilling af sådanne forbindelser, forbindelserne til anvendelse i terapi samt anvendelse af forbindelserne til fremstilling af et lægemiddel mod Pneumocystis carinii.........
HU206665B (en) Process for producing new naphtoquinone derivatives and pharmaceutical compositions containing them
CZ242994A3 (en) 1,4-naphthoquinone derivatives exhibiting anti-protozoic and anti-parasitic activity

Legal Events

Date Code Title Description
RH Patent void